The circadian variation in Anti-Müllerian hormone in patients with polycystic ovary syndrome differs significantly from normally ovulating women.
<h4>Objective</h4>[corrected] To improve the biologic understanding of the Polycystic Ovarian Syndrome (PCOS) condition by examining the circadian variation and relationship between Anti Müllerian Hormone (AMH), gonadotropins and ovarian steroids in PCOS patients compared to normally ovu...
Enregistré dans:
Auteurs principaux: | Leif Bungum, Florencia Franssohn, Mona Bungum, Peter Humaidan, Aleksander Giwercman |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/80d044d9c68a42ae9329dfdcd04e4097 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Relationship of Anti-Mullerian Hormone in Polycystic Ovary Syndrome Patients with Different Subgroups
par: Ran Y, et autres
Publié: (2021) -
Comparison of Tamoxifen and Clomiphene on Ovulation and Pregnancy Rates in Polycystic Ovary Syndrome Patients
par: S Esmaeilzadeh,, et autres
Publié: (2009) -
Induction ovulation with use of low dose HMG in patients with Clomiphene Citrate resistant polycystic ovary syndrome (PCOs)
par: T Nazari, et autres
Publié: (2003) -
Interpretation and significance of the definition of anti-Mullerian hormone in the practice of juvenile gynaecologist
par: Zaira K. Kumykova, et autres
Publié: (2021) -
Comparative effectiveness of 9 ovulation-induction therapies in patients with clomiphene citrate-resistant polycystic ovary syndrome: a network meta-analysis
par: Yiping Yu, et autres
Publié: (2017)